Edited by:
Andy T. Y. Lau: Shantou University Medical College, China
Amy Yan-Ming Xu: Shantou University Medical College, China
Cancer Cell International is presenting the Collection on 'Ubiquitin Biology and Human Health.' The aim of this collection is to gather the latest knowledge and perspectives regarding ubiquitin research.
This is an invite-only collection.
Cancer Cell International is presenting the Collection on 'Ubiquitin Biology and Human Health.'
What makes ubiquitin biology so exciting and fascinating within biomedical science in the past few decades are the biochemical behaviors that allow ubiquitylation/deubiquitylation to modulate diverse processes of life. The growing lists of ubiquitin linkage types (monoubiquitylation, multi-monoubiquitylation, or homotypic/heterotypic polyubiquitylation), ubiquitin conjugation systems, and deubiquitylation enzymes have driven the curiosity of scientists to gradually reveal the complex realm between ubiquitin machinery and its dysregulation in various human diseases including cancer.
This year marks the 19th anniversary of the Nobel Prize in Chemistry for the discovery of ubiquitin-mediated protein degradation. We are honored to have the first kickoff article in this thematic series by Professor Aaron Ciechanover, Nobel Prize laureate in Chemistry of 2004. This collection will also comprise articles from other scientists of the field; the goal is to gather the latest knowledge and perspectives regarding ubiquitin research.
This is an invite-only collection.
Image credit: © selvanegra / Getty Images / iStock
Nuclear factor-ĸB (NF-ĸB) is an important transcriptional regulator of key cellular processes, including cell cycle, immune response, and malignant transformation. We found that the ubiquitin ligase Kip1 ubiqu...
This collection invites participating authors to submit Research Articles, Data Notes, Case Reports, Study Protocols, and Database Articles. Before submitting your manuscript, please ensure you have read our submission guidelines. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Ubiquitin Biology and Human Health" from the dropdown menu.
Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.
The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.